Published in Ther Clin Risk Manag on June 01, 2005
Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res (2011) 1.01
A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. Exp Biol Med (Maywood) (2014) 0.89
Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals. Eur J Clin Pharmacol (2012) 0.82
Prescribing in care homes: the role of the geriatrician. Ther Adv Chronic Dis (2011) 0.79
Drug-induced liver injury in older adults. Ther Adv Drug Saf (2010) 0.79
Polypharmacy in the elderly. J Res Pharm Pract (2015) 0.79
A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient. Oncologist (2016) 0.75
Intensive hospital monitoring of adverse reactions to drugs. Br Med J (1969) 12.09
Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA (1990) 10.01
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing (1980) 4.30
Aging biology and geriatric clinical pharmacology. Pharmacol Rev (2004) 3.23
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol (2004) 3.23
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther (2004) 2.81
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ (2000) 2.49
Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing (2000) 2.29
Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther (2002) 2.23
Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol (2002) 2.10
Adverse drug reactions in elderly patients. Br J Clin Pharmacol (2004) 2.02
Adverse drug reactions: an investigation on an acute geriatric ward. Age Ageing (1986) 1.91
Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet (2002) 1.88
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther (2004) 1.86
The ambiguous relation between aging and adverse drug reactions. Ann Intern Med (1991) 1.82
Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc (1991) 1.80
The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol (2000) 1.79
Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother (2001) 1.76
Polypharmacy in the aged. Practical solutions. Drugs Aging (1994) 1.63
Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc (1988) 1.60
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci (2004) 1.55
The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet (1998) 1.55
When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol (2003) 1.50
Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol (2001) 1.47
Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology (2001) 1.40
Age-related pseudocapillarization of the human liver. J Pathol (2003) 1.39
Self-reported medication use for older people in England and Wales. J Clin Pharm Ther (2001) 1.37
Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol (1992) 1.31
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J (1999) 1.22
The association of age and frailty with paracetamol conjugation in man. Age Ageing (1990) 1.22
Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother (1999) 1.20
Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging (2001) 1.18
Drug metabolism and ageing. Br J Clin Pharmacol (2004) 1.15
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet (2005) 1.14
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther (1990) 1.13
Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study. J Am Geriatr Soc (1987) 1.12
Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev (1995) 1.11
Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol (2003) 1.11
Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. Drug Saf (2001) 1.08
Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet (1988) 1.08
Drug dosage in the elderly. Is it rational? Drugs Aging (1998) 1.06
Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther (1998) 1.05
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther (1999) 1.04
Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. Dan Med Bull (1998) 1.02
Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin. J Clin Pharmacol (2002) 1.00
Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs (1991) 0.97
The medicalisation of old age. BMJ (2002) 0.97
Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health (2002) 0.96
Intensive monitoring for adverse drug effects in patients discharged from acute medical wards. N Z Med J (1973) 0.94
The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev (1997) 0.94
Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol (1988) 0.93
Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging (1999) 0.91
Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res (1996) 0.91
The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin. Drug Metab Dispos (2004) 0.91
A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol (1991) 0.88
The effect of age on P-glycoprotein expression and function in the Fischer-344 rat. J Pharmacol Exp Ther (2004) 0.87
P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy. Drugs Aging (1995) 0.85
Medication use among older Australian veterans and war widows. Intern Med J (2003) 0.84
Distribution of prescription drug exposures in the elderly: description and implications. J Clin Epidemiol (1996) 0.82
Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. BMC Med (2004) 0.82
P-glycoprotein function in the elderly. Eur J Clin Pharmacol (2004) 0.78
Pharmacokinetics of pravastatin in elderly versus young men and women. Ann Pharmacother (1993) 0.78
Hypnotics. Options to help your patients stop. Aust Fam Physician (2000) 0.78
Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes. Braz J Med Biol Res (2003) 0.77
In human therapy, is the drug-drug interaction or the adverse drug reaction the issue? Can J Clin Pharmacol (2001) 0.77
The many essential interfaces of clinical pharmacology. Clin Exp Pharmacol Physiol (2001) 0.76
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol (2012) 3.57
Aging biology and geriatric clinical pharmacology. Pharmacol Rev (2004) 3.23
The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing (2009) 3.03
T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology (2006) 2.30
Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov (2012) 2.22
Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology (2005) 2.00
Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2010) 1.97
Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.89
Pain, frailty and comorbidity on older men: the CHAMP study. Pain (2008) 1.79
Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc (2005) 1.73
Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci (2009) 1.64
Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Med J Aust (2007) 1.60
How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ (2011) 1.59
Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol (2009) 1.58
The Relationship between fenestrations, sieve plates and rafts in liver sinusoidal endothelial cells. PLoS One (2012) 1.54
Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging (2008) 1.51
Prescribing in older people. Aust Fam Physician (2004) 1.49
Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs (2003) 1.47
Age-related pseudocapillarization of the human liver. J Pathol (2003) 1.39
Fenestrations and lipoproteins. Cardiovasc Pathol (2010) 1.38
Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37
Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol (2011) 1.26
Health professionals rarely record history of complementary and alternative medicines. Br J Clin Pharmacol (2005) 1.26
Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med (2012) 1.25
Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol (2007) 1.22
Drug combinations and impaired renal function -- the 'triple whammy'. Br J Clin Pharmacol (2005) 1.22
Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc (2009) 1.22
Sleep disturbances and falls in older people. J Gerontol A Biol Sci Med Sci (2007) 1.21
Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc (2011) 1.20
Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res (2011) 1.18
Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men Project. Age Ageing (2010) 1.14
Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J (2009) 1.13
Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J Struct Biol (2010) 1.13
Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol (2003) 1.11
Medication exposure may confound the association between dietary intake and frailty. J Gerontol A Biol Sci Med Sci (2013) 1.08
Understanding drug effects in older people: the role of pharmacology. JAMA Intern Med (2013) 1.07
Modifications to the drug burden index calculation may limit interpretation of its association with clinical outcomes in older adults. Neurocrit Care (2014) 1.07
Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging (2010) 1.07
Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology (2010) 1.07
The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells. Am J Physiol Gastrointest Liver Physiol (2008) 1.05
Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician (2012) 1.04
Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol (2013) 1.04
The effects of oxidative stress on the liver sieve. J Hepatol (2004) 1.03
Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc (2005) 1.03
Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc (2015) 1.01
Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol (2011) 1.01
Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res (2011) 1.01
Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome. J Gerontol A Biol Sci Med Sci (2010) 1.01
Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis (2006) 1.00
Basal activity of Kupffer cells increases with old age. J Gerontol A Biol Sci Med Sci (2007) 1.00
The liver sieve and atherosclerosis. Pathology (2012) 1.00
Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (2011) 0.99
Experimental gerontological research in Australia. Exp Gerontol (2002) 0.97
Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metab (2011) 0.97
Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters. J Gastroenterol Hepatol (2005) 0.96
Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (2014) 0.95
Liver dysfunction and heart failure. Am J Cardiol (2003) 0.95
Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. Int J Infect Dis (2010) 0.94
Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol (2012) 0.94
Discontinuation of statins in routine care settings. Ann Intern Med (2013) 0.92
Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study. Pharmacoepidemiol Drug Saf (2009) 0.92
Discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2013) 0.92
Hepatic pseudocapillarization in aged mice. Exp Gerontol (2005) 0.91
The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin. Drug Metab Dispos (2004) 0.91
Associations between frailty and serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in older Australian men: the Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci (2013) 0.91
Associations between serum 25-hydroxyvitamin D concentrations and multiple health conditions, physical performance measures, disability, and all-cause mortality: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2014) 0.91
Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf (2014) 0.91
Reactions of Pseudomonas aeruginosa pyocyanin with reduced glutathione. Acta Biochim Pol (2008) 0.90
Life extension by calorie restriction in humans. Ann N Y Acad Sci (2007) 0.90
Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging (2009) 0.90
The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J Gastroenterol Hepatol (2007) 0.89
Liver sinusoidal endothelial fenestrations in caveolin-1 knockout mice. Microcirculation (2010) 0.89
Prescription and administration of opioids to hospital in-patients, and barriers to effective use. Pain Med (2009) 0.89
Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol (2006) 0.88
Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging (2013) 0.88
Antimycin A-induced defenestration in rat hepatic sinusoidal endothelial cells. Hepatology (2003) 0.88
Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta. Placenta (2003) 0.88
The role of fat and lean mass in bone loss in older men: findings from the CHAMP study. Bone (2011) 0.87
A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother (2010) 0.87
Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol (2008) 0.87
Assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Br J Clin Pharmacol (2014) 0.87
The influence of oxygen tension on the structure and function of isolated liver sinusoidal endothelial cells. Comp Hepatol (2008) 0.87
Microscopic colitis associated with exposure to lansoprazole. Med J Aust (2006) 0.85
Effects of dietary protein to carbohydrate balance on energy intake, fat storage, and heat production in mice. Obesity (Silver Spring) (2013) 0.85
Caloric restriction reduces age-related pseudocapillarization of the hepatic sinusoid. Exp Gerontol (2007) 0.85